Adverse health outcomes for prostate cancer patients treated with radiotherapy combined with androgen-deprivation therapy: A population-based, controlled study, from Norway
Open Access
- 25 August 2025
- journal article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 1109-1116
Abstract
Background and purpose : The aim of this controlled cross-sectional, and population-based study was to evaluate adverse health outcomes (AHOs) 3 years after curative radiotherapy (RT) + androgen deprivation therapy (ADT). We also assessed Global Health/Quality of Life (QoL). Patients/material and methods: The Cancer Registry of Norway (CRN) provided data on prostate cancer (PCa) patients diagnosed in 2017–2019. All had been treated with RT+ ADT. All had completed EPIC-26 and EORTC QLQ-C30 about 3 years after RT start (n = 663). ADT duration was stratified: Short (< 9 months), intermediate (9–18 months) and long ADT (18–24 months). A group of controls were established from the general population (n = 1,817). Outcome measures were the urinary irritative/obstructive domain summary score (DSS), the bowel and sexual DSSs (EPIC-26) and QoL (EORTC QLQ-C30). Results: Compared to controls, patients had clinically important lower bowel, and sexual mean scores. Urinary irritative/obstructive DSS levels were similar. Overall, 43% (PCa patients) and 20% (controls) reported major sexual problems. In patients aged < 75 years, longer than short ADT duration significantly decreased sexual DSS. QoL was relatively unaffected. Low response rates, selection bias and a lack of pre-treatment data represent the studys´ limitations. Conclusion and Interpretation: Three years post-RT+ADT, PCa patients describe clinically important lower EPIC-26 bowel and sexual DSS compared to controls. Sexual domain levels decreased with increasing ADT duration, particularly in patients < 75 years. Our observations indicate worse AHOs than previously reported and should be considered during pre-treatment counselling of PCa patients.Keywords
This publication has 31 references indexed in Scilit:
- A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controlsQuality of Life Research, 2025
- Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide StudyEuropean Urology Oncology, 2024
- Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general populationClinical and Translational Radiation Oncology, 2022
- Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate CancerJAMA, 2020
- Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysisCancer Treatment Reviews, 2018
- Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative ReviewEuropean Urology, 2018
- Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsJAMA, 2017
- Long-term Health-related Quality of Life After Primary Treatment for Localized Prostate Cancer: Results from the CaPSURE RegistryEuropean Urology, 2015
- Erectile Dysfunction After External Beam Radiotherapy for Prostate CancerEuropean Urology, 2009
- Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatmentInternational Urology and Nephrology, 2007